Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Young Innovations, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Young Innovations, Inc.: Files with SEC for an initial public offering of 2 mil. shares at $10-12 each. The Earth City, Missouri maker of single use supplies, autoclavable instruments and other products used for dental applications plans to use anticipated proceeds of $20 mil. (assuming an IPO price of $11 per share) for debt repayment, "working capital and general corporate purposes, including making strategic acquisitions," the firm states. Young Innovations had sales of $12.1 mil. for the six months ended June 30 (up 34.2%), and net income of $1.8 mil. (up 22.6%) for the period. Underwriters Robert W. Baird & Co. and Cleary Gull Reiland & McDevitt hold an overallotment option for 300,000 additional shares...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008834

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel